IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH) sub(2)D sub(3), on osteoclast-like cell formation in normal human bone marrow cultures
A potent interleukin-6 (IL-6) antagonist (Sant 5), which binds tightly to the IL-6 alpha receptor but has impaired gp130 heterodimerization, has been developed recently by site-directed mutagenesis of human IL-6. We report here that Sant 5 inhibits IL-6-stimulated osteoclast-like multinucleated cell...
Saved in:
Published in | Journal of bone and mineral research Vol. 13; no. 3; pp. 393 - 399 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
01.03.1998
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!